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DObjective: Although it has been demonstrated that the repair rates and quality of the repair of mitral
insufficiency are superior in mitral valve reference centers, it has not been studied whether an advantage exists
for perioperative morbidity and mortality. We report 1 surgeon’s evolution over 7 years, specifically considering
the changes in perioperative morbidity and mortality.
Methods: We performed a retrospective review of 1054 patients who had undergone elective, day-of-surgery-
admission mitral valve repair by a single surgeon (D.H.A.) at our institution from April 2005 to June 2012. The
outcome variables studied were operative mortality (30-day or in-hospital mortality, if longer), length of stay,
low cardiac output state after cardiopulmonary bypass, and major morbidity.
Results: The overall operative mortality was 0.58%. Of the 1054 patients, 31% developed a low cardiac output
state postoperatively and 6.52% experienced at least 1 of the composite morbidity events. Increased aortic
crossclamp times were significantly and independently associated with a low cardiac output state, length of
stay, and morbidity. When divided by service year, a statistically and clinically significant decrease was found
in the aortic crossclamp time, despite an increase in the complexity of cases. The morbidity decreased
concurrently with the decreases in crossclamp times.
Conclusions: As the number of mitral valve repairs performed each year by a single surgeon at a single
institution increased, morbidity, including postoperative heart function and length of stay, decreased. This
was demonstrated to occur in large part from a reduction in the aortic crossclamp times, despite an increase
in the complexity of the procedures. This further demonstrates the value of reference centers for mitral valve
surgery. (J Thorac Cardiovasc Surg 2014;148:2021-6)Mitral valve (MV) repair has become the reference standard
procedure for degenerative MV disease that requires
surgical intervention.1 DegenerativeMV disease is different
from other valvular heart diseases because most of the
lesions caused by the degenerative changes are amenable
to MV repair.2 Additionally, many surgeons repair MV
lesions resulting from other causes such as endocarditis or
rheumatic heart disease. MV repair for mitral regurgitation
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The Journal of Thoracic and Carremains superior to MV replacement after 10 years to
20 years after surgery.3,4 The guidelines from the
American College of Cardiology and the American Heart
Association5 strongly encourage referral to MV reference
centers, in particular, for complex repairs, to ensure a
successful repair rate of>90%.
Although it has been clearly demonstrated that the repair
rates and repair quality are superior in reference centers,6 it
has not been studied extensively whether the immediate
perioperative course, in terms of morbidity and mortality,
will be better in a reference center. We report 1 surgeon’s
evolution by examining a consecutive series of patients
during a 7-year period, considering the changes in
perioperative morbidity and mortality after MV repair.METHODS
After receiving institutional review board approval, we performed a
retrospective review of a prospectively collected departmental database.
The database included data from all patients who had undergone elective,
day-of-surgery-admission MV repair, either isolated or combined with
another procedure, by a single surgeon (D.H.A.) from April 2005 to June
2012. A total of 1054 patients were included in the present study. The
medical record were then reviewed to obtain patient demographics and
surgical characteristics, including age, weight, height, gender, procedure
type, American Society of Anesthesiologists classification, Europeandiovascular Surgery c Volume 148, Number 5 2021
Abbreviations and Acronyms
EuroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
ICU ¼ intensive care unit
MV ¼ mitral valve
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DSystem for Cardiac Operative Risk Evaluation (EuroSCORE),7 preopera-
tive cardiac function, other comorbidities, surgical date, type of MV
dysfunction, and aortic crossclamp times. The outcome variables studied
were operative mortality (30-day or in-hospital mortality, if longer),
intensive care unit (ICU) length of stay, low cardiac output state after
cardiopulmonary bypass, hospital length of stay, and a composite of major
morbidities (because all occurred to infrequently to be analyzed
individually) that included major stroke (permanent neurologic deficit),
myocardial infarction (new Q waves on electrocardiogram), sternal wound
infection, sepsis, reoperation for bleeding, respiratory failure (requiring
tracheostomy), renal failure (requiring renal replacement therapy), and
gastrointestinal bleeding (requiring transfusion).
For the analysis of the surgery type, the patients were divided into 3
groups. One group consisted of patients who had undergone isolated MV
repair. The second group included patients who had undergone MV and
tricuspid valve repair. The third group included all patients who had
undergone MV repair with or without tricuspid repair combined with any
other cardiac operation, including a cryomaze procedure for atrial
fibrillation.
For the analysis related to the complexity of MV repair, the patients
were divided into 3 categories. Category 1 included patients with
Carpentier type I or IIIb dysfunction.8 Category 2 included all patients
with single segment posterior leaflet prolapse. Category 3 included patients
with more complex dysfunction, including multisegmental posterior leaflet
prolapse, any anterior leaflet prolapse, bileaflet prolapse, Carpentier type
IIIa dysfunction (eg, rheumatic heart disease), primary systolic anterior
motion, repeat repair of the MV, endocarditis, and complex congenital
lesions.
A low cardiac output state after cardiopulmonary bypass was defined by
the dose of epinephrine (the standard inotropic medication used at our
institution after cardiopulmonary bypass) needed when leaving the
operating room. A dose of 50 to 100 ng/kg/min was defined as a mildly
impaired cardiac output state, 100 to 150 ng/kg/min was considered
moderate, and>150 ng/kg/min was considered severe.
The procedures were performed through a midline approach in
nearly all the patients with, predominately, central cannulation forTABLE 1. Aortic crossclamp times and major morbidity by service year
Variable
2005
(Apr-Dec)
(n ¼ 64)
2006
(n ¼ 79)
2007
(n ¼ 128)
Crossclamp time (min) 179 (140-228) 183 (151-225) 151 (121-184) 1
Operative mortality 1 1
Epinephrine dose (ng/kg/min) 40 (0-80) 50 (0-100) 50 (0-100)
Epinephrine dose
 50 ng/kg/min
67 72 56
Postoperative adverse eventy 4 (6.9) 13 (16.88) 7 (5.56)
Hospital length of stay (d) 6 (5-8) 7 (5-11) 6 (5-8)
ICU length of stay (d) NA NA 2 (1-3)
Data presented as median (interquartile range), %, or n (%). P values compared the va
Kruskal-Wallis test for continuous outcomes.NA, Not available; ICU, intensive care unit. *T
myocardial infarction, sternal wound infection, sepsis, reoperation for bleeding, respiratory
and gastrointestinal bleeding (requiring transfusion).
2022 The Journal of Thoracic and Cardiovascular Surcardiopulmonary bypass. All patients received bicaval venous cannulation.
Direct aortic crossclamping and cardioplegic arrest, using cold blood
cardioplegia given in both antegrade and retrograde fashion, was used.
The cardiopulmonary bypass flow rates were maintained to provide a
perfusion index of 2.2 to 2.4 L/min/m2. The hematocrit was maintained
at>18%, and mild hypothermia (34C) was used. Lower temperatures
were only used if the patients required circulatory arrest. The MV was
accessed through a left atriotomy by dissection of Sondergaard’s groove.
The quality of the repair was assessed with saline testing and intraoperative
transesophageal echocardiography after separation from cardiopulmonary
bypass.
Statistical Analysis
The patient and disease characteristics are presented as percentages,
median and interquartile range, or mean  standard deviation. Univariate
analyses of postoperative outcomes were performed for the crossclamp
time (grouped as 0-2, 2-3, and>3 hours) and for service year, using
chi-square tests or Kruskal-Wallis tests, as appropriate. Covariate-
adjusted associations between the crossclamp time and postoperative
outcomes were determined using various regression techniques:
specifically, logistic regression for the composite of morbidities, linear
regression for the dose of epinephrine, and Cox regression for the interval
to ICU and hospital discharge. Stepwise forward selection, with both entry
and stay criteria set at 0.05, was implemented to identify the most
important risk factors for adjustment. The initial list included age, gender,
body mass index, service year, EuroSCORE, procedure type, American
Society of Anesthesiologists class (4 vs 3), preoperative medical
conditions (eg, hypertension, chronic obstructive pulmonary disease,
coronary artery disease, pulmonary hypertension, arrhythmia, and
diabetes), right and left ventricular functional grade (ie, mild, moderate,
or severe), and crossclamp time. The effects for the crossclamp time are
expressed in terms of odds ratios (for the composite of morbidities), change
(for epinephrine), and hazard ratios (for ICU and hospital length of stay),
with the 95% confidence intervals.RESULTS
A total of 1054 day-of-surgery-admission patients
underwent MV repair by 1 surgeon (D.H.A.) during the
study period, with a trend toward an increasing number of
annual cases (Table 1). The repair rate was>99.9% for
patients presenting for repair. The patient demographics,
comorbidities, and surgical characteristics are summarized
in Table 2. The overall 30-day mortality rate for the cohort2008
(n ¼ 144)
2009
(n ¼ 172)
2010
(n ¼ 170)
2011
(n ¼ 203)
2012
(Jan-Jun)
(n ¼ 94)
P
value
40 (115-169) 115 (91-139) 108 (88-135) 94 (76-114) 94 (80-114)<.001
1 1 1 1 NA*
40 (0-80) 45 (0-100) 25 (0-50) 30 (0-70) 30 (0-50) <.001
48 50 45 47 39 <.001
11 (8.46) 11 (6.4) 5 (2.94) 13 (6.4) 3 (3.3) .006
6 (5-7.5) 6 (5-7) 6 (5-7) 7 (5-8) 6 (5-7) <.001
2 (1-3) 1 (1-2) 2 (1-2) 2 (1-3) 1 (1-2) .077
lue over time and were based on chi-square test for categorical outcomes and the
oo few deaths to statistically evaluate. yThe composite of morbidities included stroke,
failure (requiring tracheostomy), renal failure (requiring renal replacement therapy),
gery c November 2014
TABLE 2. Patient and surgical characteristics (n ¼ 1054)
Variable Value
Age (y)
Mean  SD 56.94  13.33
Range 20-89
Male gender (%) 61
Height (cm) 171.19  14.12
Weight (kg) 77.37  16.55
ASA class (%)
2 1.42
3 54.17
4 44.4
EuroSCORE7
Median 2.1
Interquartile range 1.5-4.23
Preoperative hypertension (%) 66.51
COPD (%) 1.9
CAD (%) 24.48
Atrial fibrillation (%) 16.89
LV function (%)
Normal 54.46
Mild dysfunction 28.27
Moderate dysfunction 13.09
Severe dysfunction 2.66
Missing data 1.52
RV function (%)
Normal 79.13
Mild dysfunction 11.95
Moderate dysfunction 3.61
Missing data 5.31
Procedure (%)
MVonly 28.46
MV and tricuspid valve 5417
MV and other 17.36
Crossclamp time (min)
Median 120
Interquartile range 92-158
MV complexity of repair* (%)
Category 1 14
Category 2 37.5
Category 3 48.5
ASA, American Society of Anesthesiologists; EuroSCORE, European System for
Cardiac Operative Risk Evaluation; COPD, chronic obstructive pulmonary disease;
CAD, coronary artery disease; LV, left ventricular; RV, right ventricular; MV, mitral
valve; SD, standard deviation. *Category 1 included patients with Carpentier type I
or IIIB dysfunction; category 2, all patients with single segment posterior leaflet pro-
lapse; and category 3, patients with more complex dysfunctions, including multiseg-
mental posterior leaflet prolapse, any anterior leaflet prolapse, bileaflet prolapse,
Carpentier type IIIA dysfunction (ie, rheumatic heart disease), primary systolic ante-
rior motion of the anterior leaflet of the MV, repeat MV repair, endocarditis, and com-
plex congenital lesions.
TABLE 3. Outcomes (n ¼ 1054)
Outcome Value
Operative mortality* (%) 0.58
ICU length of stay (d)
Median 1
Interquartile range 1-3
Low cardiac output state (%)
Mild 21.92
Moderate 6.17
Severe 2.94
Hospital length of stay (d)
Median 6
Interquartile range 5-8
Composite of morbiditiesy (%) 6.52
ICU, Intensive care unit. *Defined as death within 30 days of the procedure or in-
hospital death. yStroke, myocardial infarction, sternal wound infection, sepsis, reoper-
ation for bleeding, respiratory failure (requiring tracheostomy), renal failure (requiring
renal replacement therapy), and gastrointestinal bleeding (requiring transfusion).
TABLE 4. Univariate analysis comparing aortic crossclamp times and
outcomes
Outcome
Aortic crossclamp time group
P
value*
1-2 h
(n ¼ 531)
2-3 h
(n ¼ 362)
>3 h
(n ¼ 161)
Operative mortalityy (n) 3 1 2 .3868
ICU length of stay (d) <.001
Median 1 2 3
Interquartile range 1-2 1-3 2-4
Low cardiac output state (%) <.001
None 77.97 64.92 48.45
Mild 17.51 23.48 32.92
Moderate 2.64 8.84 11.8
Severe 1.88 2.76 6.83
Hospital length of stay (d) <.001
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output state postoperatively, and 6.52% had 1 of the
morbidities included in the composite (Table 3).Median 6 6 7
Interquartile range 5-7 5-8 5-9
Composite of morbidities (%) 4.21 6.57 14.29 <.001
ICU, Intensive care unit. *Based on chi-square test. yDefined as death within 30 days
of the procedure or in-hospital death.Crossclamp Time
Increased aortic crossclamp times were significantly
associated with a low cardiac output state, ICU length ofThe Journal of Thoracic and Carstay, hospital length of stay, and major morbidity
(Table 4). Mortality occurred too infrequently for analysis.
Multivariate analysis using forward stepwise regression
confirmed that an increasing aortic crossclamp time was
independently associated with an increased risk of
postoperative morbidity, higher dose of epinephrine, and
prolonged interval to ICU and hospital discharge, when
controlling for all the preoperative variables (Table 5).Service Year
We then analyzed the data divided by service year and
found a statistically and clinically significant decrease in
the aortic crossclamp times over time (Table 1 and
Figure 1). The mean crossclamp times were nearly halved,
despite an increase in the number of more complex MVdiovascular Surgery c Volume 148, Number 5 2023
TABLE 5. Multivariate analyses of postoperative morbidities for crossclamp time
Outcome Model
Crossclamp time
Covariates remaining in final model
2-3 h >3 h
Overall P valueEffect* 95% CI Effect* 95% CI
Major morbidity composite Logistic 1.58 0.81-3.08 4.70 2.07-10.67 .001 Age, RV function, service year
Epinephrine (ng/kg/min) Linear 13.33 6.82-19.83 33.38 24.75-42.02 <.001 Age, gender, ASA status, RV function
ICU discharge Cox 0.74 0.63-0.88 0.51 0.38-0.70 <.001 Age, gender, EuroSCORE, RV function, CAD
Hospital discharge Cox 0.80 0.69-0.93 0.57 0.46-0.71 <.001 Age, gender, procedure type, service year,
ASA status, RV function
CI, Confidence interval; RV, right ventricular; ASA, American Society of Anesthesiologists; ICU, intensive care unit; EuroSCORE, European System for Cardiac Operative Risk
Evaluation; CAD, coronary artery disease. *Effect indicates the odds ratio, mean difference, or hazard ratio compared with the reference (crossclamp time<2 h); an odds ratio
>1 was associated with an increased risk of morbidity and a hazard ratio<1 was associated with less likelihood of ICU or hospital discharge.
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Dprocedures and no difference in the number of cases with a
concurrent cardiac procedure (Table 6). Morbidity
decreased concurrently with the decreases in crossclamp
times (Table 1). The other preoperative variables associated
with longer aortic crossclamp times were preoperative right
ventricular dysfunction and when the procedure involved
more than isolated MV repair.
DISCUSSION
The present study found that as the number ofMV repairs
performed by a single surgeon in a MV reference center
increased, the rate of morbidity decreased. The mortality
rate was too low to analyze. The decrease was demonstrated
to be due, in large part, to a reduction in the aortic
crossclamp times during the study period, despite an
increase in the number of more complex types of MV
operations and no difference in the number of MV
procedures with other concurrent cardiac procedures.
Previous work in degenerative MV disease from our centerFIGURE 1. When analyzed by service year, a statistically and clin
2024 The Journal of Thoracic and Cardiovascular Surhas shown that this was not at the expense of the quality of
the repair.1,9
Myocardial protection strategies with intermittent
cardioplegia, cooling, and blood are intended to extend
the safe period that the heart can remain arrested without
compromising adequate return of function.10 However,
despite this, longer aortic crossclamp times have been
shown in multiple studies to correlate significantly with
major postoperative morbidity and mortality in both low-
and high-risk patients, with the effect increasing
with increasing crossclamp times.11-13 Al-Sarraf and
colleagues14 found that each incremental increase of
1 minute in the crossclamp time was associated with an
increase in mortality. The morbidities associated with pro-
longed crossclamp times have included a low cardiac output
state, prolonged ventilation time, renal complications,
blood transfusion, and prolonged hospital stays. This
association has continued into the modern era of cardiac
surgery despite improvements in myocardial protection.14ically significant decrease in aortic crossclamp times was seen.
gery c November 2014
TABLE 6. Type of surgery and complexity of mitral valve dysfunction by service year
2005 (Apr-Dec)
(n ¼ 64)
2006
(n ¼ 79)
2007
(n ¼ 128)
2008
(n ¼ 144)
2009
(n ¼ 172)
2010
(n ¼ 170)
2011
(n ¼ 203)
2012 (Jan-Jun)
(n ¼ 94) P value*
Procedure <.001
MVonly 31 (48.5) 13 (16.5) 10 (7.8) 46 (31.9) 44 (25.6) 50 (29.4) 82 (40.4) 24 (25.5)
MV and tricuspid valve 28 (43.8) 40 (50.6) 83 (64.8) 69 (47.9) 102 (59.3) 95 (55.9) 101 (49.8) 53 (56.4)
MV and other 5 (7.8) 26 (32.9) 35 (27.3) 29 (20.2) 26 (15.1) 25 (14.7) 20 (9.8) 17 (18.1)
MV complexity of repairy <.001
Category 1 8 (12.5) 22 (27.8) 24 (18.8) 24 (16.7) 23 (13.4) 18 (10.6) 20 (9.6) 9 (9.6)
Category 2 30 (46.9) 25 (31.7) 46 (35.9) 48 (33.3) 70 (40.7) 67 (39.4) 77 (37.9) 32 (34.0)
Category 3 26 (40.6) 32 (40.5) 58 (45.3) 72 (50) 79 (45.9) 85 (50) 106 (52.4) 53 (56.4)
Data presented as n (% of service year).MV, Mitral valve. *Based on chi-square test. yCategory 1 included patients with Carpentier type I or IIIB dysfunction; category 2, patients
with single segment posterior leaflet prolapse; and category 3, patients with more complex dysfunctions, including multisegmental posterior leaflet prolapse, any anterior leaflet
prolapse, bileaflet prolapse, Carpentier type IIIA dysfunction (ie, rheumatic heart disease), primary systolic anterior motion of the anterior leaflet of the mitral valve, repeat
MV repair, endocarditis, and complex congenital lesions.
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DIn the present study, we analyzed 1 surgeon performing
1 type of operation to remove the confounders of
different cardioprotection techniques or cardiopulmonary
bypass strategies. Longer aortic crossclamp times were
associated with major morbidity, even when controlling
for preoperative heart function, other comorbidities, and
the EuroSCORE. Shorter crossclamp times led to
better heart function after cardiopulmonary bypass,
which led to a quicker recovery and shorter hospital length
of stay.
A number of factors likely contributed to the decrease in
aortic crossclamp times during the study period. These
included greater surgeon experience and improved surgical
techniques. An example would be the addition of ‘‘magic
sutures’’ and artificial neochords to the surgeon’s
armentarium.9
The decrease in morbidity could also have resulted from
other factors. With more cases performed each year, the rest
of the team, including the surgical, anesthesiology,
perfusion, and nursing team, would become more
experienced and adept at treating this class of patient. The
postoperative ICU treatment also likely improved. One
study of cardiac surgery found that the cumulative surgical
attending and fellow paired experience was more of a factor
than the individual surgeon experience in decreasing the
aortic crossclamp times.15
That we were able to demonstrate a decreased length of
stay could have far reaching implications in the current
era of healthcare reform. A decreased length of stay is likely
to drive down costs. Thus, surgical reference centers could
be more cost-effective than less experienced centers, further
increasing their value. Although the length of stay might not
seem short compared with that at other institutions, this
might have been a reflection of the greater complexity of
cases performed.
The limitations of the present study included its
retrospective, single-center design and that the clinical
care was not standardized; thus, the effects of unmeasuredThe Journal of Thoracic and Carconfounding variables could not be excluded. Thus,
statistical correlation might not imply causation. We
defined a low cardiac output state by the use of epinephrine.
It is possible that these patients did not have a low cardiac
output state but were given epinephrine owing to a
perception that it was needed to aid in recovery. The
decrease in use during the study period might then just
reflect recognition that such doses were not necessary and
was not a reflection of patient status. The decrease in the
epinephrine requirement also could have resulted from
subtle changes in the cardioplegia solution or delivery and
adjunctive measures such as topical cooling for right
ventricular preservation. Additionally, factors other than
improved operator surgical experience could have contrib-
uted to the decrease in the morbidities studied. The decrease
in the ICU length of stay could have resulted from factors
other than the decreasing aortic crossclamp times, such as
early extubation protocols and early mobilization.
A high-volume MV surgery reference center with a
single surgeon’s highly specialized team with a near
100% repair rate was studied.1 A number of other factors
could limit extrapolation of our results to other centers.
First, the surgeon (D.H.A.) studied generally takes as long
as necessary to repair a MV and accepts prolonged aortic
crossclamp times if necessary for a complex repair. Thus,
the aortic crossclamp times were relatively long. Second,
even mild mitral regurgitation after repair has generally
not been considered acceptable and will result in a return
to cardiopulmonary bypass and aortic crossclamping to
perfect the repair. Third, the surgeon repairs all types of
degenerative MV disease, including more complex
scenarios such as bileaflet or anterior leaflet involvement,
significant annular calcification, reoperations, and older
patients. This could also explain the relatively long aortic
crossclamp times. Finally, it is possible that because of
the success of the surgeon with MV repair, patient referrals
began to occur earlier in the disease process, biasing the
results toward better outcomes.diovascular Surgery c Volume 148, Number 5 2025
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DCONCLUSIONS
The results of the present study have shown that as the
number of MV repairs performed by a single surgeon at a
single institution increased, the morbidity, including
postoperative heart function and length of stay, decreased.
Although the results from our single study are not
sufficient to conclude that these results can be extrapolated
to other centers, we hope it will stimulate additional
research on the subject. As we continue to strive for greater
value in healthcare, our findings could prove extremely
important.
The authors thank Julie A. Swain, MD, Professor of
Cardiothoracic Surgery, Icahn School of Medicine at Mount Sinai
(New York, NY), for her comments on our report.
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